MET

MetLife
D

MET

Arincen73/100B

MetLife financials

Yes. MetLife earned 5.13B USD of net income over the last twelve months, 6.2% of its revenue. It made a profit in 30 of its 31 fiscal years since 1995. Its last loss was in fiscal year 2009.

Revenue (TTM)
82.29B USD
Net income (TTM)
5.13B USD
Free cash flow (TTM)
15.00B USD
Cash and short-term investments
354.48B USD
Total debt
21.68B USD
Shareholders' equity
22.23B USD

Cash, debt and equity as of 30 Sept 2026.

MetLife earnings

Next earnings · Q4 FY2026
EPS estimate
2.62 USD
Revenue estimate
20.68B USD
Last quarter · Q3 FY2026
EPS2.78Beat +0.4%Revenue20.52BBeat +3.4%

Revenue

ReportedEstimate

EPS

ReportedEstimate
PeriodReport dateEPS estimateReported EPSSurpriseEPS growthRevenue estimateReported revenueSurpriseRevenue growth
Q3 FY20272.86——+3.05%20.86B——+1.64%
Q2 FY20272.81——+15.57%20.48B——+7.35%
Q1 FY20272.57——+6.09%20.43B——+3.81%
Q4 FY20262.62——+1.55%20.68B——-13.14%
Q3 FY20262.772.78+0.36%+18.80%19.86B20.52B+3.36%+21.57%
Q2 FY20262.302.43+5.65%+20.30%19.67B19.08B-3.00%+10.01%
Q1 FY20262.272.42+6.61%+23.47%19.49B19.68B+1.00%+7.65%
Q4 FY20252.342.58+10.26%+24.04%27.22B23.81B-12.51%+29.59%
Q3 FY20252.312.34+1.30%+20.00%18.64B16.88B-9.44%-8.45%
Q2 FY20252.152.02-6.05%-11.40%18.53B17.34B-6.45%-2.71%

MetLife growth and profitability

Full income statement
Revenue (TTM)
82.29B USD
Net income (TTM)
5.13B USD
Gross margin
29.23%
Operating margin
8.44%
Net margin
6.23%

Revenue / Net income

Revenue Net income Net margin
PeriodRevenueGrowthNet incomeGrowthGross marginOperating marginNet marginEBITDAGrowth
FY202577.08B+10.22%3.38B-23.66%36.36%6.05%4.38%6.48B-12.18%
FY202469.94B+3.29%4.43B+180.48%27.17%8.04%6.33%7.37B+87.85%
FY202367.71B-0.38%1.58B-70.14%25.53%3.19%2.33%3.93B-50.78%
FY202267.97B+7.26%5.28B-22.92%27.86%9.36%7.77%7.98B-21.29%
FY202163.37B-6.66%6.86B+26.78%26.57%13.44%10.82%10.13B+19.78%

How MetLife makes its money

Revenue77.08B 100.0%
Cost of revenue49.06B 63.6%
Gross profit28.02B 36.4%
Other operating expenses23.36B 30.3%
Operating income4.66B 6.0%
Tax1.26B 1.6%
Other expense24.00M 0.0%
Net income3.38B 4.4%

FY2025, in USD. Each band is as wide as its money; the percentage is its share of revenue.

MetLife revenue breakdown

By product

FY2025
Prepaid legal plans and administrative-only contracts: 26.1%Vision fee for service arrangements: 23.0%Other revenue from service contracts from customers: 17.7%Fee-based investment management services: 15.1%Administrative Service: 12.1%Distribution Service: 5.8%26.1%Prepaid legal plans and administrative-only contracts23.0%Vision fee for service arrangements17.7%Other revenue from service contracts from customers15.1%Fee-based investment management services12.1%Administrative Service5.8%Distribution Service
SegmentRevenueShare of revenueChange on the year
Prepaid legal plans and administrative-only contracts637.00M26.1%+11.4%
Vision fee for service arrangements561.00M23.0%+4.7%
Other revenue from service contracts from customers432.00M17.7%+35.4%
Fee-based investment management services369.00M15.1%-6.3%
Administrative Service295.00M12.1%+8.1%
Distribution Service142.00M5.8%-6.0%

By region

FY2025
Asia: 56.4%Latin America: 27.3%Europe, Middle East And Africa: 16.4%56.4%Asia27.3%Latin America16.4%Europe, Middle East And Africa
RegionRevenueShare of revenueChange on the year
Asia238.00M56.4%-97.8%
Latin America115.00M27.3%-98.4%
Europe, Middle East And Africa69.00M16.4%—

Operating and free cash flow

Full cash flow statement
Operating cash flow Free cash flow
Fiscal yearOperating cash flowFree cash flow
FY202518.11B18.11B
FY202415.12B15.12B
FY202314.26B14.26B
FY202211.37B11.37B
FY202112.83B12.83B
FY202011.51B11.51B
FY201913.93B13.93B
FY20189.53B9.53B
FY201712.72B12.72B
FY201614.66B14.66B

MetLife financial health

Full balance sheet
Cash and short-term investments
354.48B USD
Total debt
21.68B USD
Net cash
332.81B USD
Free cash flow (TTM)
15.00B USD
Current ratio
2.29
Debt to equity
0.98
Piotroski score
8 / 9
Altman Z-score
0.68

Cash, debt and free cash flow

Cash and short-term investments Total debt Free cash flow
Fiscal yearCash and short-term investmentsTotal debtFree cash flow
FY2025125.34B20.18B18.11B
FY2024108.78B18.72B15.12B
FY2023316.83B18.83B14.26B
FY2022313.32B17.98B11.37B
FY2021367.50B17.43B12.83B

Assets, liabilities and equity

Total assets Total liabilities Shareholders' equity
Fiscal yearTotal assetsTotal liabilitiesShareholders' equity
FY2025745.17B716.25B28.40B
FY2024677.46B649.75B27.45B
FY2023687.58B657.33B30.02B
FY2022663.07B632.95B29.88B
FY2021759.71B691.96B67.48B
FY2020795.15B720.33B74.56B
FY2019740.46B674.08B66.14B
FY2018687.54B634.58B52.74B
FY2017719.89B661.02B58.68B
FY2016898.76B831.06B67.53B

MetLife valuation

Price to earnings ratio (TTM)
13.22
Forward P/E (FY2026)
9.97
Price to sales (TTM)
0.78
Price to book
2.89
EV / EBITDA (TTM)
-34.58

Capital structure

Market capitalization
64.15B USD
+
Total debt
21.68B USD
−
Cash and short-term investments
354.48B USD
=
Enterprise value
-268.66B USD

Valuation over time

P/EForward P/EForward P/E · EstimateEstimate
Fiscal yearP/EForward P/EP/SP/BEV/EBITDA
FY2028 (est.)8.25————
FY2027 (est.)9.148.25———
FY2026 (est.)9.979.14———
Now (TTM)13.229.240.782.89-34.58
FY202516.457.710.681.857.82
FY202413.699.430.812.067.47
FY202336.348.070.741.6812.38
FY202211.409.900.831.896.79
FY20218.128.990.810.764.83

MetLife against its own history

Each figure in the latest fiscal year against the same figure from FY2021 to FY2025: the range, its median (the line) and the latest (the dot, green on the good side of the median). The P/E is today's against its daily readings of five years.

Its peers: Aflac, Prudential Financial, Globe Life, Unum Group, Voya Financial, and Primerica, the US Insurance - Life companies closest to it in size, each in its own latest fiscal year: their median (the line) and its rank among them, first being the best.

  • P/E (today)Below its median13.2
    6.540.5
  • Gross marginHighest in 5 years36.4%
    25.5%36.4%
    Against its peers: 5 of 7Peers' median 38.6%
  • Operating marginBelow its median6.0%
    3.2%13.4%
    Against its peers: 6 of 7Peers' median 16.0%
  • Net marginBelow its median4.4%
    2.3%10.8%
    Against its peers: 7 of 7Peers' median 14.0%
  • Return on equityAt its median11.9%
    5.3%17.7%
    Against its peers: 5 of 7Peers' median 12.8%
  • Free cash flow marginHighest in 5 years23.5%
    16.7%23.5%
    Against its peers: 2 of 7Peers' median 15.9%
  • Revenue growthHighest in 5 years10.2%
    -6.7%10.2%
    Against its peers: 1 of 7Peers' median -2.4%
  • EPS growthBelow its median-19.2%
    -71.3%228.2%
    Against its peers: 5 of 7Peers' median 10.1%
  • Debt to EBITDAAbove its median3.12×
    1.72×4.80×
    Against its peers: 5 of 7Peers' median 2.44×
  • Current ratioBelow its median0.65
    0.551.47
    Against its peers: 5 of 6Peers' median 9.66

Peers: US companies of the same industry (of its sector when the industry has too few) from a tenth to ten times its market value, the six closest in size. Updated weekly.

MetLife dividends

Annual dividend
2.37 USD
Dividend yield (indicated)
2.32%
Payout ratio
30.38%
Years of dividend growth
13
Frequency
Quarterly
Next payment
0.59 USD
Last ex-dividend date
3 Nov 2026
Next payment date
8 Dec 2026

Dividends per share

Year2025202420232022202120202019201820172016
Dividends per share2.252.162.061.981.901.821.741.661.471.40

MetLife ownership

Institutions
75.02%
Institutional holders
1,517 (+71)
Free float
83.66%

Who owns the shares

Institutions 75.0% Others 25.0%
As of 30 Jun 2026

Shares free to trade

Free float 525.77M shares ·83.7% Closely held 102.67M shares ·16.3%

Closely held shares belong to insiders, founders and owners of more than 5%, and seldom change hands. The free float is the rest: the shares anyone can buy and sell.

Insider trading

QuarterPurchasesSalesShares acquiredShares disposed of
Q3 2026001.36K18.48K
Q2 20260029.43K0.00
Q1 202600344.34K122.49K
Q4 20250018.93K4.42K

Shares outstanding

Basic shares Diluted shares Change in diluted shares
Fiscal yearBasic sharesDiluted sharesChange in diluted shares
FY2025664.96M664.96M-6.49%
FY2024689.21M711.10M-6.73%
FY2023762.43M762.43M-5.74%
FY2022779.10M808.90M-6.96%
FY2021825.54M869.40M-4.80%

Common questions about MetLife's financials

Source: Financial Modeling Prep